114 related articles for article (PubMed ID: 9119907)
1. Parametric images of benzodiazepine receptor concentration using a partial-saturation injection.
Delforge J; Spelle L; Bendriem B; Samson Y; Syrota A
J Cereb Blood Flow Metab; 1997 Mar; 17(3):343-55. PubMed ID: 9119907
[TBL] [Abstract][Full Text] [Related]
2. Changes in GABAA receptor properties in amygdala kindled animals: in vivo studies using [11C]flumazenil and positron emission tomography.
Liefaard LC; Ploeger BA; Molthoff CF; de Jong HW; Dijkstra J; van der Weerd L; Lammertsma AA; Danhof M; Voskuyl RA
Epilepsia; 2009 Jan; 50(1):88-98. PubMed ID: 18727682
[TBL] [Abstract][Full Text] [Related]
3. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle.
Lassen NA; Bartenstein PA; Lammertsma AA; Prevett MC; Turton DR; Luthra SK; Osman S; Bloomfield PM; Jones T; Patsalos PN
J Cereb Blood Flow Metab; 1995 Jan; 15(1):152-65. PubMed ID: 7798333
[TBL] [Abstract][Full Text] [Related]
5. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain.
Frey KA; Holthoff VA; Koeppe RA; Jewett DM; Kilbourn MR; Kuhl DE
Ann Neurol; 1991 Nov; 30(5):663-72. PubMed ID: 1662476
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of benzodiazepine receptors in human brain using the partial saturation method.
Delforge J; Spelle L; Bendriem B; Samson Y; Bottlaender M; Papageorgiou S; Syrota A
J Nucl Med; 1996 Jan; 37(1):5-11. PubMed ID: 8544001
[TBL] [Abstract][Full Text] [Related]
7. Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors.
Millet P; Graf C; Buck A; Walder B; Westera G; Broggini C; Arigoni M; Slosman D; Bouras C; Ibáñez V
J Cereb Blood Flow Metab; 2000 Nov; 20(11):1587-603. PubMed ID: 11083234
[TBL] [Abstract][Full Text] [Related]
8. Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches.
Delforge J; Syrota A; Bottlaender M; Varastet M; Loc'h C; Bendriem B; Crouzel C; Brouillet E; Maziere M
J Cereb Blood Flow Metab; 1993 May; 13(3):454-68. PubMed ID: 8478404
[TBL] [Abstract][Full Text] [Related]
9. Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.
Delforge J; Pappata S; Millet P; Samson Y; Bendriem B; Jobert A; Crouzel C; Syrota A
J Cereb Blood Flow Metab; 1995 Mar; 15(2):284-300. PubMed ID: 7860662
[TBL] [Abstract][Full Text] [Related]
10. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.
Price JC; Mayberg HS; Dannals RF; Wilson AA; Ravert HT; Sadzot B; Rattner Z; Kimball A; Feldman MA; Frost JJ
J Cereb Blood Flow Metab; 1993 Jul; 13(4):656-67. PubMed ID: 8391018
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography.
Brouillet E; Chavoix C; Khalili-Varasteh M; Bottlaender M; Hantraye P; Yorke JC; Maziere M
Mol Pharmacol; 1990 Oct; 38(4):445-50. PubMed ID: 2172764
[TBL] [Abstract][Full Text] [Related]
12. Wavelet analysis of dynamic PET data: application to the parametric imaging of benzodiazepine receptor concentration.
Millet P; Ibáñez V; Delforge J; Pappata S; Guimón J
Neuroimage; 2000 May; 11(5 Pt 1):458-72. PubMed ID: 10806032
[TBL] [Abstract][Full Text] [Related]
13. Altered in vitro and in vivo flumazenil binding in human epileptogenic neocortex.
Nagy F; Chugani DC; Juhász C; da Silva EA; Muzik O; Kupsky W; Canady A; Watson C; Shah J; Chugani HT
J Cereb Blood Flow Metab; 1999 Sep; 19(9):939-47. PubMed ID: 10478645
[TBL] [Abstract][Full Text] [Related]
14. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy.
Macdonald GA; Frey KA; Agranoff BW; Minoshima S; Koeppe RA; Kuhl DE; Shulkin BL; Lucey MR
Hepatology; 1997 Aug; 26(2):277-82. PubMed ID: 9252134
[TBL] [Abstract][Full Text] [Related]
15. [11C]flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification.
Sanabria-Bohórquez SM; Labar D; Levêque P; Bol A; De Volder AG; Michel C; Veraart C
Eur J Nucl Med; 2000 Nov; 27(11):1674-83. PubMed ID: 11105824
[TBL] [Abstract][Full Text] [Related]
16. Absolute quantification by positron emission tomography of the endogenous ligand.
Delforge J; Bottlaender M; Pappata S; Loc'h C; Syrota A
J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptors.
Li J; Fish RL; Cook SM; Tattersall FD; Atack JR
Neuropharmacology; 2006 Jul; 51(1):168-72. PubMed ID: 16697018
[TBL] [Abstract][Full Text] [Related]
18. Parameter and index images of benzodiazepine receptor concentration in the brain.
Millet P; Delforge J; Mauguiere F; Pappata S; Cinotti L; Frouin V; Samson Y; Bendriem B; Syrota A
J Nucl Med; 1995 Aug; 36(8):1462-71. PubMed ID: 7629596
[TBL] [Abstract][Full Text] [Related]
19. [11C]flumazenil PET: activity images versus parametric images for the detection of neocortical epileptic foci.
Niimura K; Muzik O; Chugani DC; Shen C; Chugani HT
J Nucl Med; 1999 Dec; 40(12):1985-91. PubMed ID: 10616875
[TBL] [Abstract][Full Text] [Related]
20. Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.
Salmi E; Aalto S; Hirvonen J; Långsjö JW; Maksimow AT; Oikonen V; Metsähonkala L; Virkkala J; Någren K; Scheinin H
Neuroimage; 2008 Jun; 41(2):260-9. PubMed ID: 18411060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
